CN105412673A - 一种治疗桥本氏病的药物及其制备方法 - Google Patents
一种治疗桥本氏病的药物及其制备方法 Download PDFInfo
- Publication number
- CN105412673A CN105412673A CN201510983640.3A CN201510983640A CN105412673A CN 105412673 A CN105412673 A CN 105412673A CN 201510983640 A CN201510983640 A CN 201510983640A CN 105412673 A CN105412673 A CN 105412673A
- Authority
- CN
- China
- Prior art keywords
- weight portion
- radix
- herba
- medicine
- weight
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000003814 drug Substances 0.000 title claims abstract description 84
- 208000001204 Hashimoto Disease Diseases 0.000 title claims abstract description 30
- 208000030836 Hashimoto thyroiditis Diseases 0.000 title claims abstract description 30
- 238000000034 method Methods 0.000 title claims abstract description 10
- 229940079593 drug Drugs 0.000 title abstract description 20
- 238000011282 treatment Methods 0.000 claims abstract description 48
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims abstract description 29
- 240000001008 Dimocarpus longan Species 0.000 claims abstract description 26
- 235000000235 Euphoria longan Nutrition 0.000 claims abstract description 26
- 241000222336 Ganoderma Species 0.000 claims abstract description 25
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 68
- 210000000582 semen Anatomy 0.000 claims description 48
- 239000000463 material Substances 0.000 claims description 34
- 239000008187 granular material Substances 0.000 claims description 29
- 241000533849 Gleditsia Species 0.000 claims description 28
- 239000002023 wood Substances 0.000 claims description 25
- 239000002775 capsule Substances 0.000 claims description 24
- 239000000284 extract Substances 0.000 claims description 24
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 claims description 24
- 241000218989 Trichosanthes Species 0.000 claims description 22
- 239000006071 cream Substances 0.000 claims description 20
- 239000000843 powder Substances 0.000 claims description 20
- 238000010992 reflux Methods 0.000 claims description 20
- 239000000203 mixture Substances 0.000 claims description 16
- 238000002360 preparation method Methods 0.000 claims description 16
- 238000001035 drying Methods 0.000 claims description 12
- 235000019359 magnesium stearate Nutrition 0.000 claims description 12
- 239000002552 dosage form Substances 0.000 claims description 10
- 238000001914 filtration Methods 0.000 claims description 8
- 238000005325 percolation Methods 0.000 claims description 8
- 239000002904 solvent Substances 0.000 claims description 8
- 229920001353 Dextrin Polymers 0.000 claims description 4
- 239000004375 Dextrin Substances 0.000 claims description 4
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 4
- 229920000168 Microcrystalline cellulose Polymers 0.000 claims description 4
- 229920002472 Starch Polymers 0.000 claims description 4
- 229930006000 Sucrose Natural products 0.000 claims description 4
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 4
- 238000009835 boiling Methods 0.000 claims description 4
- 235000019425 dextrin Nutrition 0.000 claims description 4
- FPAFDBFIGPHWGO-UHFFFAOYSA-N dioxosilane;oxomagnesium;hydrate Chemical compound O.[Mg]=O.[Mg]=O.[Mg]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O FPAFDBFIGPHWGO-UHFFFAOYSA-N 0.000 claims description 4
- 239000008101 lactose Substances 0.000 claims description 4
- 239000013521 mastic Substances 0.000 claims description 4
- 235000019813 microcrystalline cellulose Nutrition 0.000 claims description 4
- 239000008108 microcrystalline cellulose Substances 0.000 claims description 4
- 229940016286 microcrystalline cellulose Drugs 0.000 claims description 4
- 238000002156 mixing Methods 0.000 claims description 4
- 230000008569 process Effects 0.000 claims description 4
- 239000007921 spray Substances 0.000 claims description 4
- 238000005507 spraying Methods 0.000 claims description 4
- 239000008107 starch Substances 0.000 claims description 4
- 235000019698 starch Nutrition 0.000 claims description 4
- 229960004793 sucrose Drugs 0.000 claims description 4
- 230000000694 effects Effects 0.000 abstract description 17
- 210000000952 spleen Anatomy 0.000 abstract description 17
- 230000001737 promoting effect Effects 0.000 abstract description 11
- 210000002216 heart Anatomy 0.000 abstract description 10
- 235000008216 herbs Nutrition 0.000 abstract description 10
- 230000017531 blood circulation Effects 0.000 abstract description 8
- 230000002936 tranquilizing effect Effects 0.000 abstract description 6
- 210000004185 liver Anatomy 0.000 abstract description 5
- 230000036039 immunity Effects 0.000 abstract description 4
- 240000006509 Gynostemma pentaphyllum Species 0.000 abstract description 3
- 235000002956 Gynostemma pentaphyllum Nutrition 0.000 abstract description 3
- 240000002853 Nelumbo nucifera Species 0.000 abstract description 3
- 241001080798 Polygala tenuifolia Species 0.000 abstract description 3
- 235000008529 Ziziphus vulgaris Nutrition 0.000 abstract description 3
- 230000002708 enhancing effect Effects 0.000 abstract description 3
- 241000931143 Gleditsia sinensis Species 0.000 abstract description 2
- 241000574434 Jasminum laurifolium Species 0.000 abstract description 2
- 235000006508 Nelumbo nucifera Nutrition 0.000 abstract description 2
- 235000006510 Nelumbo pentapetala Nutrition 0.000 abstract description 2
- 241000205578 Thalictrum Species 0.000 abstract description 2
- 230000009286 beneficial effect Effects 0.000 abstract description 2
- 231100000331 toxic Toxicity 0.000 abstract description 2
- 230000002588 toxic effect Effects 0.000 abstract description 2
- 241000743763 Aeschynanthus acuminatus Species 0.000 abstract 1
- 241000758794 Asarum Species 0.000 abstract 1
- 240000007133 Cordia dichotoma Species 0.000 abstract 1
- 235000005943 Cordia dichotoma Nutrition 0.000 abstract 1
- 241000331432 Cynanchum wilfordii Species 0.000 abstract 1
- 241000878003 Dendrolycopodium obscurum Species 0.000 abstract 1
- 241001620231 Ficus pandurata Species 0.000 abstract 1
- 244000014908 Gaultheria leucocarpa var. yunnanensis Species 0.000 abstract 1
- 244000137852 Petrea volubilis Species 0.000 abstract 1
- 241001547453 Sarcococca Species 0.000 abstract 1
- 240000000038 Ziziphus mauritiana Species 0.000 abstract 1
- 235000006545 Ziziphus mauritiana Nutrition 0.000 abstract 1
- 239000000796 flavoring agent Substances 0.000 description 25
- 235000019634 flavors Nutrition 0.000 description 25
- 206010062717 Increased upper airway secretion Diseases 0.000 description 15
- 210000004072 lung Anatomy 0.000 description 15
- 208000026435 phlegm Diseases 0.000 description 15
- 210000001685 thyroid gland Anatomy 0.000 description 15
- 210000004369 blood Anatomy 0.000 description 14
- 239000008280 blood Substances 0.000 description 14
- 241000411851 herbal medicine Species 0.000 description 12
- 206010011224 Cough Diseases 0.000 description 11
- 241000699670 Mus sp. Species 0.000 description 11
- 235000009508 confectionery Nutrition 0.000 description 10
- 235000013399 edible fruits Nutrition 0.000 description 10
- 208000002193 Pain Diseases 0.000 description 9
- 208000024891 symptom Diseases 0.000 description 8
- 230000003203 everyday effect Effects 0.000 description 7
- 210000003734 kidney Anatomy 0.000 description 7
- 238000003745 diagnosis Methods 0.000 description 6
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 5
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 5
- 230000037396 body weight Effects 0.000 description 5
- 206010022437 insomnia Diseases 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 210000003205 muscle Anatomy 0.000 description 5
- 231100000614 poison Toxicity 0.000 description 5
- 210000002784 stomach Anatomy 0.000 description 5
- 208000006820 Arthralgia Diseases 0.000 description 4
- 241000345998 Calamus manan Species 0.000 description 4
- 206010007247 Carbuncle Diseases 0.000 description 4
- 206010012735 Diarrhoea Diseases 0.000 description 4
- 240000008397 Ganoderma lucidum Species 0.000 description 4
- 208000008454 Hyperhidrosis Diseases 0.000 description 4
- 206010033557 Palpitations Diseases 0.000 description 4
- 230000007812 deficiency Effects 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 238000003304 gavage Methods 0.000 description 4
- 208000014674 injury Diseases 0.000 description 4
- 235000012950 rattan cane Nutrition 0.000 description 4
- 210000002435 tendon Anatomy 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 239000003440 toxic substance Substances 0.000 description 4
- 230000008736 traumatic injury Effects 0.000 description 4
- 206010000087 Abdominal pain upper Diseases 0.000 description 3
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 3
- 206010010774 Constipation Diseases 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- 235000001637 Ganoderma lucidum Nutrition 0.000 description 3
- 244000126002 Ziziphus vulgaris Species 0.000 description 3
- 206010003549 asthenia Diseases 0.000 description 3
- 208000006673 asthma Diseases 0.000 description 3
- 210000000988 bone and bone Anatomy 0.000 description 3
- 230000001914 calming effect Effects 0.000 description 3
- 230000004087 circulation Effects 0.000 description 3
- 208000001848 dysentery Diseases 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 230000004345 fruit ripening Effects 0.000 description 3
- 208000003532 hypothyroidism Diseases 0.000 description 3
- 230000002989 hypothyroidism Effects 0.000 description 3
- 231100000957 no side effect Toxicity 0.000 description 3
- 230000001717 pathogenic effect Effects 0.000 description 3
- 238000010926 purge Methods 0.000 description 3
- 230000002040 relaxant effect Effects 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- 208000004371 toothache Diseases 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 241001289295 Asarum sieboldii Species 0.000 description 2
- 241000218645 Cedrus Species 0.000 description 2
- 241000218691 Cupressaceae Species 0.000 description 2
- 208000000059 Dyspnea Diseases 0.000 description 2
- 206010013975 Dyspnoeas Diseases 0.000 description 2
- 206010018498 Goitre Diseases 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- 208000004356 Hysteria Diseases 0.000 description 2
- 206010023126 Jaundice Diseases 0.000 description 2
- 240000008415 Lactuca sativa Species 0.000 description 2
- 235000003228 Lactuca sativa Nutrition 0.000 description 2
- 206010062049 Lymphocytic infiltration Diseases 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 206010068319 Oropharyngeal pain Diseases 0.000 description 2
- 201000007100 Pharyngitis Diseases 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 241000219100 Rhamnaceae Species 0.000 description 2
- 241000612118 Samolus valerandi Species 0.000 description 2
- 206010040943 Skin Ulcer Diseases 0.000 description 2
- 241000468460 Thalictrum aquilegiifolium Species 0.000 description 2
- 241000130764 Tinea Species 0.000 description 2
- 208000002474 Tinea Diseases 0.000 description 2
- 241000209140 Triticum Species 0.000 description 2
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 2
- 238000011047 acute toxicity test Methods 0.000 description 2
- 230000003208 anti-thyroid effect Effects 0.000 description 2
- 229940043671 antithyroid preparations Drugs 0.000 description 2
- 230000001174 ascending effect Effects 0.000 description 2
- 235000019658 bitter taste Nutrition 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 206010006451 bronchitis Diseases 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 210000000038 chest Anatomy 0.000 description 2
- 229940121657 clinical drug Drugs 0.000 description 2
- 208000012839 conversion disease Diseases 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 230000006735 deficit Effects 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 238000002651 drug therapy Methods 0.000 description 2
- 239000003172 expectorant agent Substances 0.000 description 2
- 230000003419 expectorant effect Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000011049 filling Methods 0.000 description 2
- 201000003872 goiter Diseases 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 208000035861 hematochezia Diseases 0.000 description 2
- 230000037315 hyperhidrosis Effects 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- 201000008383 nephritis Diseases 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 230000001575 pathological effect Effects 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 231100000019 skin ulcer Toxicity 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 230000035900 sweating Effects 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 230000035922 thirst Effects 0.000 description 2
- 241000905376 Actaea dahurica Species 0.000 description 1
- 241000906577 Actaea heracleifolia Species 0.000 description 1
- 241000208327 Apocynaceae Species 0.000 description 1
- 241000758795 Aristolochiaceae Species 0.000 description 1
- 206010003694 Atrophy Diseases 0.000 description 1
- 208000023275 Autoimmune disease Diseases 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 241001072256 Boraginaceae Species 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- 206010006458 Bronchitis chronic Diseases 0.000 description 1
- 241001415830 Bubo Species 0.000 description 1
- 241000208195 Buxaceae Species 0.000 description 1
- 206010006895 Cachexia Diseases 0.000 description 1
- 208000017897 Carcinoma of esophagus Diseases 0.000 description 1
- 241000722731 Carex Species 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 206010008479 Chest Pain Diseases 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 206010010726 Conjunctival oedema Diseases 0.000 description 1
- MFYSYFVPBJMHGN-ZPOLXVRWSA-N Cortisone Chemical compound O=C1CC[C@]2(C)[C@H]3C(=O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 MFYSYFVPBJMHGN-ZPOLXVRWSA-N 0.000 description 1
- 244000241257 Cucumis melo Species 0.000 description 1
- 235000015510 Cucumis melo subsp melo Nutrition 0.000 description 1
- 241000219104 Cucurbitaceae Species 0.000 description 1
- 244000235531 Cupressus funebris Species 0.000 description 1
- 241000028057 Cynanchum auriculatum Species 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 241001106478 Dilleniaceae Species 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- 206010014080 Ecchymosis Diseases 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 241001632410 Eleutherococcus senticosus Species 0.000 description 1
- 208000004232 Enteritis Diseases 0.000 description 1
- 208000010228 Erectile Dysfunction Diseases 0.000 description 1
- 201000000297 Erysipelas Diseases 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 241000218218 Ficus <angiosperm> Species 0.000 description 1
- 240000003537 Ficus benghalensis Species 0.000 description 1
- 206010016807 Fluid retention Diseases 0.000 description 1
- 206010070245 Foreign body Diseases 0.000 description 1
- 208000036119 Frailty Diseases 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 240000004859 Gamochaeta purpurea Species 0.000 description 1
- 208000005577 Gastroenteritis Diseases 0.000 description 1
- 241000735588 Gaultheria Species 0.000 description 1
- 241001112537 Gesneriaceae Species 0.000 description 1
- 241000146384 Glaux Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 241000550772 Helwingia himalaica Species 0.000 description 1
- 208000037319 Hepatitis infectious Diseases 0.000 description 1
- 206010020850 Hyperthyroidism Diseases 0.000 description 1
- 206010020880 Hypertrophy Diseases 0.000 description 1
- 208000015817 Infant Nutrition disease Diseases 0.000 description 1
- 235000010254 Jasminum officinale Nutrition 0.000 description 1
- 240000005385 Jasminum sambac Species 0.000 description 1
- XUIIKFGFIJCVMT-LBPRGKRZSA-N L-thyroxine Chemical compound IC1=CC(C[C@H]([NH3+])C([O-])=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 XUIIKFGFIJCVMT-LBPRGKRZSA-N 0.000 description 1
- 208000019395 Lactation disease Diseases 0.000 description 1
- 206010024453 Ligament sprain Diseases 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
- 241000222065 Lycoperdon Species 0.000 description 1
- 241000195948 Lycopodiaceae Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 208000005647 Mumps Diseases 0.000 description 1
- 206010028748 Nasal obstruction Diseases 0.000 description 1
- 241000209477 Nymphaeaceae Species 0.000 description 1
- 206010030155 Oesophageal carcinoma Diseases 0.000 description 1
- 241000207834 Oleaceae Species 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 1
- 235000011613 Pinus brutia Nutrition 0.000 description 1
- 241000018646 Pinus brutia Species 0.000 description 1
- 240000002924 Platycladus orientalis Species 0.000 description 1
- 241000768494 Polymorphum Species 0.000 description 1
- 244000197580 Poria cocos Species 0.000 description 1
- 235000008599 Poria cocos Nutrition 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 241001448530 Rohdea japonica Species 0.000 description 1
- 241001093760 Sapindaceae Species 0.000 description 1
- 241001656875 Sarcococca ruscifolia Species 0.000 description 1
- 241001558929 Sclerotium <basidiomycota> Species 0.000 description 1
- 206010039897 Sedation Diseases 0.000 description 1
- 208000004078 Snake Bites Diseases 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 208000010040 Sprains and Strains Diseases 0.000 description 1
- 208000005718 Stomach Neoplasms Diseases 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 206010042576 Suppressed lactation Diseases 0.000 description 1
- 241001671200 Tetracera asiatica Species 0.000 description 1
- 240000000315 Tetracera scandens Species 0.000 description 1
- 241000685608 Thalictrum cultratum Species 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 206010053615 Thermal burn Diseases 0.000 description 1
- AUYYCJSJGJYCDS-LBPRGKRZSA-N Thyrolar Chemical class IC1=CC(C[C@H](N)C(O)=O)=CC(I)=C1OC1=CC=C(O)C(I)=C1 AUYYCJSJGJYCDS-LBPRGKRZSA-N 0.000 description 1
- 241000975594 Trichosanthes rosthornii Species 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 208000003443 Unconsciousness Diseases 0.000 description 1
- 206010046814 Uterine prolapse Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- FJJCIZWZNKZHII-UHFFFAOYSA-N [4,6-bis(cyanoamino)-1,3,5-triazin-2-yl]cyanamide Chemical compound N#CNC1=NC(NC#N)=NC(NC#N)=N1 FJJCIZWZNKZHII-UHFFFAOYSA-N 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 208000011279 abdominal lump Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 231100000403 acute toxicity Toxicity 0.000 description 1
- 230000007059 acute toxicity Effects 0.000 description 1
- CKMXBZGNNVIXHC-UHFFFAOYSA-L ammonium magnesium phosphate hexahydrate Chemical compound [NH4+].O.O.O.O.O.O.[Mg+2].[O-]P([O-])([O-])=O CKMXBZGNNVIXHC-UHFFFAOYSA-L 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000037444 atrophy Effects 0.000 description 1
- 230000005784 autoimmunity Effects 0.000 description 1
- 210000002469 basement membrane Anatomy 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 238000005452 bending Methods 0.000 description 1
- 238000009534 blood test Methods 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 201000008275 breast carcinoma Diseases 0.000 description 1
- 208000016335 bubo Diseases 0.000 description 1
- 230000002308 calcification Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000003915 cell function Effects 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 208000007451 chronic bronchitis Diseases 0.000 description 1
- 208000019902 chronic diarrheal disease Diseases 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 238000003759 clinical diagnosis Methods 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 230000001186 cumulative effect Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000005202 decontamination Methods 0.000 description 1
- 230000003588 decontaminative effect Effects 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 238000003748 differential diagnosis Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 208000026500 emaciation Diseases 0.000 description 1
- 230000002996 emotional effect Effects 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 201000005619 esophageal carcinoma Diseases 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 206010017758 gastric cancer Diseases 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 230000003760 hair shine Effects 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 208000005252 hepatitis A Diseases 0.000 description 1
- 206010019847 hepatosplenomegaly Diseases 0.000 description 1
- 208000021760 high fever Diseases 0.000 description 1
- 238000010562 histological examination Methods 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 230000007365 immunoregulation Effects 0.000 description 1
- 229960003444 immunosuppressant agent Drugs 0.000 description 1
- 230000001861 immunosuppressant effect Effects 0.000 description 1
- 239000003018 immunosuppressive agent Substances 0.000 description 1
- 238000009169 immunotherapy Methods 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 238000011221 initial treatment Methods 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- 230000001983 lactogenic effect Effects 0.000 description 1
- 229960003918 levothyroxine sodium Drugs 0.000 description 1
- 239000009090 lianfang Substances 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 231100001252 long-term toxicity Toxicity 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000002751 lymph Anatomy 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 230000036210 malignancy Effects 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 239000002398 materia medica Substances 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 239000012567 medical material Substances 0.000 description 1
- 238000002483 medication Methods 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 201000002266 mite infestation Diseases 0.000 description 1
- 208000010805 mumps infectious disease Diseases 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 239000002547 new drug Substances 0.000 description 1
- 230000001473 noxious effect Effects 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 238000003305 oral gavage Methods 0.000 description 1
- 210000004681 ovum Anatomy 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 230000000849 parathyroid Effects 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- VLTRZXGMWDSKGL-UHFFFAOYSA-M perchlorate Inorganic materials [O-]Cl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-M 0.000 description 1
- VLTRZXGMWDSKGL-UHFFFAOYSA-N perchloric acid Chemical compound OCl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-N 0.000 description 1
- 210000004180 plasmocyte Anatomy 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 208000037920 primary disease Diseases 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 208000008128 pulmonary tuberculosis Diseases 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 201000003068 rheumatic fever Diseases 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- 201000009890 sinusitis Diseases 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 201000011549 stomach cancer Diseases 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 229910052567 struvite Inorganic materials 0.000 description 1
- 230000009747 swallowing Effects 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 229940036555 thyroid hormone Drugs 0.000 description 1
- 239000005495 thyroid hormone Substances 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000820 toxicity test Toxicity 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
- A61K36/424—Gynostemma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/074—Ganoderma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/11—Pteridophyta or Filicophyta (ferns)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/13—Coniferophyta (gymnosperms)
- A61K36/14—Cupressaceae (Cypress family), e.g. juniper or cypress
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/19—Acanthaceae (Acanthus family)
- A61K36/195—Strobilanthes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/254—Acanthopanax or Eleutherococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/26—Aristolochiaceae (Birthwort family), e.g. heartleaf
- A61K36/268—Asarum (wild ginger)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/27—Asclepiadaceae (Milkweed family), e.g. hoya
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/30—Boraginaceae (Borage family), e.g. comfrey, lungwort or forget-me-not
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
- A61K36/315—Isatis, e.g. Dyer's woad
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
- A61K36/428—Trichosanthes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/45—Ericaceae or Vacciniaceae (Heath or Blueberry family), e.g. blueberry, cranberry or bilberry
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/483—Gleditsia (locust)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/62—Nymphaeaceae (Water-lily family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/69—Polygalaceae (Milkwort family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/704—Polygonum, e.g. knotweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/72—Rhamnaceae (Buckthorn family), e.g. buckthorn, chewstick or umbrella-tree
- A61K36/725—Ziziphus, e.g. jujube
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/77—Sapindaceae (Soapberry family), e.g. lychee or soapberry
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/85—Verbenaceae (Verbena family)
- A61K36/855—Clerodendrum, e.g. glorybower
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Alternative & Traditional Medicine (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种治疗桥本氏病的药物及其制备方法,药物中各种原料药材为:石榕、绞股蓝、酸枣仁、大青叶、玉柏、锡叶藤、莲子、龙眼肉、刺五加、胃友、隔山消、马尾连、升麻、茯神、透骨香、侧柏叶、浮小麦、细辛、琴叶榕、皂荚、大枣、桂叶素馨、灵芝、栝楼皮、破布木和远志。本发明的有益效果是:本发明具有活血通络、清肝泻火的功效,兼有健脾化痰、养心安神和滋阴降火的作用,具有起效快、有效率高、疗效确切、治疗疗程短、无毒副作用,价格低等优势;另外,还能够增强机体的免疫力,达到抗桥本氏病的作用。
Description
技术领域
本发明涉及药物制剂技术领域,特别涉及一种治疗桥本氏病的药物及其制备方法。
背景技术
桥本氏病是慢性淋巴细胞性甲状腺炎的简称,属中医“瘿病”范畴。它是以甲状腺组织中大量淋巴细胞浸润和血清中出现大量抗甲状腺抗体为主要病理特征的自身免疫性疾病。桥本氏病常见于中年女性,很多患者病程早期临床症状不明显,多以甲状腺弥漫性肿大而就诊,可有颈部紧束感,表现为甲状腺肿,起病缓慢,常在无意中发现,体积约为正常甲状腺的2-3倍,表面光滑,质地坚韧有弹性如橡皮,明显结节则少见,无压痛,与四周无粘连,可随吞咽运动活动,部分患者可有短时间甲亢症状出现,但最终绝大部分患者会出现甲状腺功能减退。
患者病理改变主要表现为,腺体大多呈弥漫性肿大,质地坚实,表面苍白,切面均匀呈分叶状,无坏死或钙化。初期甲状腺腺泡上皮呈炎症性破坏、基膜断裂,胞浆呈现不同程度的伊红着色,表示细胞功能正常,并有甲状腺腺泡增生等变化,为本病的特征性病理。
后期甲状腺明显萎缩,腺泡变小和数目减少,空腔中含极少胶样物质。最具特征的改变为间质各处有大量浆细胞和淋巴细胞浸润及淋巴滤泡形成,其中偶可找到异物巨细胞。此外尚有中等度的结缔组织增生。
西医对HT的治疗,甲状腺激素替代治疗是终身的,一旦中断,甲减会在一定时间后重现,甚至加重。免疫疗法是近年研究的热点,短期使皮质激素,也可采用雷公藤或其它免疫抑制剂疗,但大量临床资料表明对自身免疫性反应本身不具显的免疫调节作用,更多患者在甲状腺功能纠正后长时间抗体滴度不能恢复正常,高滴度甲状腺自身抗体不降,复发率高。更由于全身免疫抑制剂的严重副作用,使人有所顾虑。而对于手术治疗,尽管有人认为,在HT基础上发生甲状腺恶性肿瘤的可能极大,主张对明确诊断者,尤其是细针穿刺细胞学检查发现异常细胞及放射性核素检查表现为冷结节的HT患者,应该及时手术。但大多数内分泌学专家认为,HT一般不宜手术治疗,只有在患者出现明显压迫症状或考虑恶变可能时才考虑手术治疗。因此,对于如何正确、有效、安全地治疗HT,西医目前遇到了不小的困惑。
目前西药治疗:治标不治本,不利于治疗,而且常用有依赖性和副作用。
发明内容
本发明所要解决的技术问题在于,提供一种治疗桥本氏病的药物及其制备方法,本发明具有活血通络、清肝泻火的功效,兼有健脾化痰、养心安神和滋阴降火的作用,具有起效快、有效率高、疗效确切、治疗疗程短、无毒副作用,价格低等优势;另外,还能够增强机体的免疫力,达到抗桥本氏病的作用。
为了解决上述技术问题,本发明提供一种治疗桥本氏病的药物,其中,包括以下原料药材:绞股蓝、酸枣仁、大青叶、玉柏、莲子、龙眼肉、刺五加、胃友、马尾连、升麻、茯神、侧柏叶、浮小麦、细辛、琴叶榕、皂荚、大枣、灵芝、栝楼皮、破布木和远志。
所述药物中各原料药材的重量份数比为:绞股蓝10-20重量份、酸枣仁12-32重量份、大青叶15-25重量份、玉柏11-31重量份、莲子14-28重量份、龙眼肉13-33重量份、刺五加10-22重量份、胃友9-18重量份、马尾连13-27重量份、升麻9-15重量份、茯神15-30重量份、侧柏叶9-12重量份、浮小麦15-35重量份、细辛14-28重量份、琴叶榕12-36重量份、皂荚2-4重量份、大枣16-42重量份、灵芝14-36重量份、栝楼皮12-22重量份、破布木10-30重量份和远志15-35重量份。
所述药物中各原料药材的重量份数比为:绞股蓝12-20重量份、酸枣仁14-30重量份、大青叶15-22重量份、玉柏12-30重量份、莲子15-25重量份、龙眼肉14-32重量份、刺五加12-20重量份、胃友10-16重量份、马尾连15-25重量份、升麻10-14重量份、茯神15-30重量份、侧柏叶9-12重量份、浮小麦15-35重量份、细辛15-28重量份、琴叶榕12-35重量份、皂荚2-3重量份、大枣20-40重量份、灵芝15-35重量份、栝楼皮13-21重量份、破布木13-30重量份和远志15-35重量份。
所述药物中各原料药材的重量份数比为:绞股蓝16重量份、酸枣仁28重量份、大青叶20重量份、玉柏14重量份、莲子25重量份、龙眼肉30重量份、刺五加16重量份、胃友12重量份、马尾连24重量份、升麻12重量份、茯神30重量份、侧柏叶11重量份、浮小麦33重量份、细辛25重量份、琴叶榕32重量份、皂荚2重量份、大枣35重量份、灵芝22重量份、栝楼皮18重量份、破布木30重量份和远志25重量份。
所述药物中各原料药材还包括:锡叶藤、隔山消、透骨香、桂叶素馨和石榕。
所述药物中各原料药材的重量份数比为:绞股蓝10-20重量份、酸枣仁12-32重量份、大青叶15-25重量份、玉柏11-31重量份、莲子14-28重量份、龙眼肉13-33重量份、刺五加10-22重量份、胃友9-18重量份、马尾连13-27重量份、升麻9-15重量份、茯神15-30重量份、侧柏叶9-12重量份、浮小麦15-35重量份、细辛14-28重量份、琴叶榕12-36重量份、皂荚2-4重量份、大枣16-42重量份、灵芝14-36重量份、栝楼皮12-22重量份、破布木10-30重量份、远志15-35重量份、锡叶藤12-24重量份、隔山消10-30重量份、透骨香3-5重量份、桂叶素馨15-25重量份和石榕10-20重量份。
所述药物中各原料药材的重量份数比为:绞股蓝16重量份、酸枣仁28重量份、大青叶20重量份、玉柏14重量份、莲子25重量份、龙眼肉30重量份、刺五加16重量份、胃友12重量份、马尾连24重量份、升麻12重量份、茯神30重量份、侧柏叶11重量份、浮小麦33重量份、细辛25重量份、琴叶榕32重量份、皂荚2重量份、大枣35重量份、灵芝22重量份、栝楼皮18重量份、破布木30重量份、远志25重量份、锡叶藤13重量份、隔山消20重量份、透骨香3重量份、桂叶素馨22重量份和石榕14重量份。
当所述药物的剂型为颗粒剂时,其制备方法包括以下步骤:
第一步,将所述原料药材按所述比例混合,加相对于混合物4-8倍的醇浓度为85%-95%的乙醇,加热至沸腾回流3-5小时,过滤,采用渗漉法以每分钟1-2ml的速度缓缓渗漉,收集渗漉液,随后在真空度0.06-0.09Mpa下减压浓缩至50-60℃时相对密度为1.04-1.10的膏体,喷雾干燥,喷雾干燥机的进风温度160-175℃、出风温度80-85℃,随后粉碎成粉末,制成干膏粉;
第二步,在获得的干膏粉中加入相对于干膏粉质量0.2-0.4倍的蔗糖粉和0.1-0.2倍的糊精,制成颗粒,于40-50℃干燥,获得颗粒剂。
当所述药物的剂型为胶囊剂时,其制备方法包括以下步骤:
第一步,将所述原料药材按比例混合,加入相对于混合物质量2-4倍的醇浓度为85-95%的乙醇,加热回流1-3小时,提取,过滤获得第一提取液;过滤获得的药渣再加入相对于所述药渣质量1-2倍的醇浓度为85-95%的乙醇,加热回流1-3小时,提取,过滤获得第二提取液;将第一提取液和第二提取液合并,减压浓缩除去乙醇溶剂,干燥,获得干膏;
第二步,将第一步获得的干膏放置在超微粉碎机中粉碎1-2小时,粉碎,过筛,获得300目-400目的超微细粉;
第三步,在第二步获得的超微细粉中依次加入滑石粉、硬脂酸镁,进行混匀处理,即得胶囊内容物;所述超微细粉、硬脂酸镁和滑石粉的重量比为100∶0.15-0.5:0.15-0.5,将所述胶囊内容物装入胶囊壳体中,即得胶囊剂成品。
当所述药物的剂型为片剂时,其制备方法包括以下步骤:
第一步,将所述原料药材按比例混合,加入相对于混合物质量3~5倍的醇浓度为85%-95%的乙醇,加热回流4-6小时,提取,过滤获得第一提取液;过滤获得的药渣再加入相对于所述药渣质量2-4倍的醇浓度为90%-95%的乙醇,加热回流1-3小时,提取,过滤获得第二提取液;将第一提取液和第二提取液合并,减压浓缩除去乙醇溶剂,干燥,获得干膏;
第二步,将第一步获得的干膏放置在超微粉碎机中粉碎1-3小时,粉碎,过筛,获得400目-500目的超微细粉;
第三步,将第二步获得的超微细粉,加入相对于其质量0.1-0.2倍的微晶纤维素、0.15-0.3倍乳糖、0.2-0.3倍的淀粉,过筛,混合均匀,制粒,干燥,加入相对于超微细粉质量0.025-0.04倍硬脂酸镁,整粒,压片,制成。
本发明的有益效果是:本发明具有活血通络、清肝泻火的功效,兼有健脾化痰、养心安神和滋阴降火的作用,具有起效快、有效率高、疗效确切、治疗疗程短、无毒副作用,价格低等优势;另外,还能够增强机体的免疫力,达到抗桥本氏病的作用。
具体实施方式
本发明以活血通络和清肝泻火为主要治疗原则,治疗桥本氏病,其中,包括以下原料药材:石榕、绞股蓝、酸枣仁、大青叶、玉柏、锡叶藤、莲子、龙眼肉、刺五加、胃友、隔山消、马尾连、升麻、茯神、透骨香、侧柏叶、浮小麦、细辛、琴叶榕、皂荚、大枣、桂叶素馨、灵芝、栝楼皮、破布木和远志。
其中,上述原料药材的药理如下:
破布木:别名:青桐木、青桐翠木、纸鹞高树。来源:紫草科破布木CordiadichotomaForst.f.,以根、果入药。性味:微甘,平。主治:行气止痛,化痰止咳。
桂叶素馨:别名:大黑骨头、岭南茉莉。来源:木犀科桂叶素馨JasminumlaurifoliumRoxb.,以全株入药。性味:苦,寒。主治:清热解毒,消炎利尿,消肿散瘀。
锡叶藤:别名:涩叶藤、糙米藤、水车藤。来源:五桠果科(锡叶藤科)锡叶藤Tetraceraasiatica(Lour.)Hoogl.;毛果锡叶藤T.scandens(L.)Merr.,以根、叶、藤入药。性味:酸、涩,平。主治:收敛止泻,消肿止痛。主治腹泻,便血,肝脾肿大,子宫脱垂,白带,风湿关节痛。
琴叶榕:别名:牛奶子树、铁牛入石。来源:桑科榕属植物琴叶榕FicuspandurataHance,以根或叶入药。全年采根,晒干。叶夏季采。性味:甘,温。主治:行气活血,舒筋活络。
远志:别名:小草、细草、小鸡腿、细叶远志、线茶。来源:本品为远志科植物远志PolygalatenuifoliaWilld.或卵叶远志PolygalasibiricaL.的干燥根。春、秋二季采挖,除去须根及泥沙,晒干。性味:苦、辛、温。归经:归心、肾、肺经。主治:安神益智,祛痰,消肿。
皂荚:出处:《本经》。别名:鸡栖子(《广志》),皂角(《肘后方》),大皂荚(《千金方》),长皂荚(《本草图经》),悬刀(《外丹本草》),长皂角(《仁斋直指方》),大皂角(《纲目》)。来源:为豆科植物皂荚的果实。秋季果实成热时采摘,晒干。性味:辛,温,微毒。主治:祛风痰,除湿毒,杀虫。治中风口眼歪斜,头风头痛,咳嗽痰喘,肠风便血,下痢噤口,痈肿便毒,疮癣疥癞。
侧柏叶:别名:扁柏、香柏、柏树、柏子树。来源:本品为柏科植物侧柏Platycladusorientalis(L.)Franco的干燥枝梢及叶。多在夏、秋二季采收,阴干。性味:苦、涩,寒。归经:归肺、肝、脾经。主治:凉血止血,生发乌发。
栝楼皮:出处:《雷公炮炙论》。别名:栝楼壳(《中药形性经验鉴别法》),瓜壳(《四川中药志》)。来源:为葫芦科植物栝楼或双边栝楼等的果皮。9~10月采收果实。对半切开,取出果肉和种子,将果皮洗净,先翻出里面晾晒,后晒外面。如遇雨天,应烘干,以免霉烂,烘时勿使火力过旺,并应依次翻动,以免烘熟。性味:甘,寒。①《饮片新参》:"甘苦,微凉。"②《中药志》:"甘,寒。"归经:入肺、胃经。《四川中药志》:"入肺、胃、大肠三经。"主治:润肺化痰,利气宽胸。治痰热咳嗽,咽痛,胸痛,吐血,衄血,消渴,便秘,痈疮肿毒。①《本草便读》:"清肺。"②《医学衷中参西录》:"清肺,敛肺,宁嗽,定喘。"③《饮片新参》:"宽胸痹,化热痰,生津润肺。"④《中药形性经验鉴别法》:"润肺,止消渴,消肿疮毒。"⑤《中药志》:"涤痰结,舒肝郁。治痰热咳嗽,胸胁作痛。"⑥《四川中药志》:"润肺降气,止咳祛痰。治咽喉疼痛,大便燥结及乳痈。"⑦《广东中药》:"治吐、衄,燥渴,咽痛,便结。"
绞股蓝:别名:七叶胆、小苦药、公罗锅底。来源:葫芦科绞股蓝属植物绞股蓝Gynostemmapentaphyllum(Thunb.)Makino,以根状茎入药。秋季采集,洗净晒干,研粉。性味:苦,寒。主治:清热解毒,止咳祛痰。用于慢性支气管炎,传染性肝炎,肾炎炎,胃肠炎。
升麻:别名:莽牛卡架、龙眼根、窟窿牙根。来源:本品为毛茛科植物大三叶升麻CimicifugaheracleifoliaKom.、兴安升麻Cimicifugadahurica(Turcz.)Maxim.或升麻CimicifugafoetidaL.的干燥根茎。秋季采挖,除去泥沙,晒至须根干时,燎去或除去须根,晒干。性味:辛、微甘,微寒。归经:归肺、脾、胃、大肠经。主治:发表透疹,清热解毒,升举阳气。
莲子:别名:莲肉、莲米。来源:本品为睡莲科植物莲NelumbonuciferaGaertn.的干燥成熟种子。除去莲心者称莲肉。秋季果实成熟时采割莲房,取出果实,除去果皮,干燥。性味:甘、涩,平。归经:归脾、肾、心经。主治:补脾止泻,益肾涩精,养心安神。用于脾虚久泻,遗精带下,心悸失眠。
大枣:来源:本品为鼠李科枣属植物枣ZiziphusjujubaMill.var.inermis(Bunge)Rehd.的干燥成熟果实。秋季果实成熟时采收,晒干。其根、树皮亦入药,随时可采。性味:甘,温。归经:归脾、胃经。主治:果(大枣):补中益气,养血安神。用于脾虚食少,乏力便溏,妇人脏躁。
胃友:出处:《云南中草药》。别名:叶上花、清香桂、万年青(《云南中草药》),土丹皮、大风消(江西《草药手册》),野樱桃(《昆明民间常用草药》)。来源:为黄杨科植物野扇花的根。全年可采,鲜用或切片阴干。主治:祛风通络,活血止痛。①《云南中草药》:"活络,止痛。治胃痛,跌打损伤。"②江西《草药手册》:"活血舒筋,祛风消肿。"
大青叶:性味:苦,寒。归经:归心、胃经。主治:清热解毒,凉血消斑。用于温邪入营,高热神昏,发斑发疹,黄疸,热痢,痄腮,喉痹,丹毒,痈肿。
隔山消:出处:《纲目》。别名:隔山撬(《分类草药性》),隔山锹(《天宝本草》)。来源:为萝藦科植物耳叶牛皮消的块根。秋季采收,洗净,晒干。性味:①《贵阳民间药草》:"甘苦,平,无毒。"②《陕西中草药》:"甘微辛,平。"主治:养阴补虚,健脾消食。治虚损劳伤,痢疾,疳积,胃痛饱胀,白带,疮癣。《陕西中草药》:"滋阴养血,健脾顺气,镇静止痛,催乳。治胃痛腹胀,虚劳,肾虚腰痛,阳萎,小儿痞块,白带,乳汁不足。"
龙眼肉:别名:龙眼、桂圆、圆眼。来源:本品为无患子科龙眼属植物龙眼DimocarpuslonganLour.的假种皮。夏、秋二季采收成熟果实,干燥,除去壳、核,晒至干爽不黏。性味:甘,温。归经:归心、脾经。主治:补益心脾,养血安神。用于气血不足,心悸怔忡,健忘失眠,血虚萎黄。
茯神:别名:茯神木。来源:茯神:茯苓菌核中间(白茯苓)抱有松根或细松木心者的部份。多切成薄方块,坚实。茯神木:为茯神中的木心。多为弯曲不直的松根,外部带有残留的茯苓,显白色或灰色,内部仍为木质,质松体轻,无皮,略似朽木。性味:甘、平。主治:宁心安神。
石榕:别名:大叶榕藤、石壁风、牛奶树。来源:苦苣苔科芒毛苣苔属植物芒毛苣苔AeschynanthusacuminatusWall.[A.chinensisGardn.etChamp.],以全株或根、茎、叶入药。夏秋采集,晒干。性味:辛、淡,凉。主治:清热化痰,利水消肿,祛瘀散结。用于支气管炎,哮喘,肺结核,肾炎水肿,胃癌,食道癌,肝癌,乳腺癌,肺癌;外用治跌打损伤,烧烫伤,痈肿疮疖。
酸枣仁:别名:山枣仁、山酸枣。来源:本品为鼠李科植物酸枣ZiziphusjujubaMill.var.spinosa(Bunge)HuexH.F.Chou的干燥成熟种子。秋末冬初采收成熟果实,除去果肉及核壳,收集种子,晒干。性味:甘、酸,平。归经:归肝、胆、心经。主治:补肝,宁心,敛汗,生津。用于虚烦不眠,惊悸多梦,体虚多汗,津伤口渴。
浮小麦:来源:禾本科小麦属植物小麦TriticumaestivumL.的干燥轻浮瘪瘦的果实。果实成熟时采收,取瘪瘦轻浮与未脱净皮的麦粒,去杂质,筛去灰屑,用水漂洗,晒干。性味:甘,凉。主治:止虚汗,养心安神。用于体虚多汗,脏躁症。
灵芝:别名:灵芝草、菌灵芝、木灵芝。来源:本品为多孔菌科真菌赤芝Ganodermalucidum(Leyss.exFr.)Karst.或紫芝GanodermasinenseZhao,XuetZhang的干燥子实体。全年采收,除去杂质,剪除附有朽木、泥沙或培养基质的下端菌柄,阴干或在40~50℃烘干。性味:甘,平。归经:归心、肺、肝、肾经。主治:补气安神,止咳平喘。用于眩晕不眠,心悸气短,虚劳咳喘。
细辛:来源:本品为马兜铃科植物北细辛AsarumheterotropoidesFr.Schmidtvar.mandshuricum(Maxim.)Kitag.、汉城细辛AsarumsieboldiiMiq.var.seoulenseNakai或华细辛AsarumsieboldiiMiq.的干燥全草。前二种习称“辽细辛”。夏季果熟期或初秋采挖,除去泥沙,阴干。性味:辛,温。归经:归心、肺、肾经。主治:祛风散寒,通窍止痛,温肺化饮。用于风寒感冒,头痛,牙痛,鼻塞鼻渊,风湿痹痛,痰饮喘咳。
马尾连:别名:马尾黄连。来源:为毛茛科唐松草属植物多叶唐松草ThalictrumfoliolosumDC.及高原唐松草T.cultratumWall.[T.deciternatumBoiv],以根部入药。春、秋季将根挖出,剪去地上茎叶,洗去泥土,晒干。性味:苦,寒。主治:清热燥湿,泻火解毒。用于肠炎,痢疾,黄疸,目赤肿痛。
玉柏:别名:伸筋草[甘肃]。来源:蕨类石松科玉柏LycopodiumobscurumL.,以全草入药。性味:辛,微温。主治:祛风通络。主治风湿疼痛,肢体麻木,跌打扭伤及鸡爪风等症。
刺五加:来源:本品为五加科植物刺五加Acanthopanaxsenticosus(Rupr.etMaxim.)Harms的干燥、根及根茎或茎。春、秋二季采收,洗净,干燥。性味:辛、微苦,温。归经:归脾、肾、心经。主治:益气健脾,补肾安神。用于脾肾阳虚,体虚乏力,食欲不振,腰膝酸痛,失眠多梦。
透骨香:出处:《贵阳民间药草》。来源:为杜鹃花科植物云南白珠树的茎叶。夏季采收,晒干。性味:辛,温。①《滇南本草》:"性温,味辛辣,有小毒。"②《贵阳民间药草》:"辛,温,无毒。"③《云南中草药》:"辛,平。"主治:祛风除湿,活血通络。治风湿关节痛,水撒,跌打损伤,牙痛,湿疹。①《滇南本草》:"治痰火,筋骨疼痛,泡酒用之良。其梗,洗风寒湿痹,筋骨疼痛,暖骨透热,熬水洗之。"②《贵阳民间药草》:"治风湿关节疼痛,跌打损伤。"③《广西药植名录》:"行气,消肿,止咳化痰。治牙痛,劳伤,蛇伤,风湿,痧气,皮肤痛痒。"④《贵州草药》:"祛风除湿,舒筋活血。"⑤《昆明民间常用草药》:"活络透骨。"
所述药物中各原料药材的重量份数比为:绞股蓝10-20重量份、酸枣仁12-32重量份、大青叶15-25重量份、玉柏11-31重量份、莲子14-28重量份、龙眼肉13-33重量份、刺五加10-22重量份、胃友9-18重量份、马尾连13-27重量份、升麻9-15重量份、茯神15-30重量份、侧柏叶9-12重量份、浮小麦15-35重量份、细辛14-28重量份、琴叶榕12-36重量份、皂荚2-4重量份、大枣16-42重量份、灵芝14-36重量份、栝楼皮12-22重量份、破布木10-30重量份和远志15-35重量份。
所述药物中各原料药材的重量份数比为:绞股蓝12-20重量份、酸枣仁14-30重量份、大青叶15-22重量份、玉柏12-30重量份、莲子15-25重量份、龙眼肉14-32重量份、刺五加12-20重量份、胃友10-16重量份、马尾连15-25重量份、升麻10-14重量份、茯神15-30重量份、侧柏叶9-12重量份、浮小麦15-35重量份、细辛15-28重量份、琴叶榕12-35重量份、皂荚2-3重量份、大枣20-40重量份、灵芝15-35重量份、栝楼皮13-21重量份、破布木13-30重量份和远志15-35重量份。
所述药物中各原料药材的重量份数比为:绞股蓝16重量份、酸枣仁28重量份、大青叶20重量份、玉柏14重量份、莲子25重量份、龙眼肉30重量份、刺五加16重量份、胃友12重量份、马尾连24重量份、升麻12重量份、茯神30重量份、侧柏叶11重量份、浮小麦33重量份、细辛25重量份、琴叶榕32重量份、皂荚2重量份、大枣35重量份、灵芝22重量份、栝楼皮18重量份、破布木30重量份和远志25重量份。
所述药物中各原料药材还包括:锡叶藤、隔山消、透骨香、桂叶素馨和石榕。
所述药物中各原料药材的重量份数比为:绞股蓝10-20重量份、酸枣仁12-32重量份、大青叶15-25重量份、玉柏11-31重量份、莲子14-28重量份、龙眼肉13-33重量份、刺五加10-22重量份、胃友9-18重量份、马尾连13-27重量份、升麻9-15重量份、茯神15-30重量份、侧柏叶9-12重量份、浮小麦15-35重量份、细辛14-28重量份、琴叶榕12-36重量份、皂荚2-4重量份、大枣16-42重量份、灵芝14-36重量份、栝楼皮12-22重量份、破布木10-30重量份、远志15-35重量份、锡叶藤12-24重量份、隔山消10-30重量份、透骨香3-5重量份、桂叶素馨15-25重量份和石榕10-20重量份。
所述药物中各原料药材的重量份数比为:绞股蓝16重量份、酸枣仁28重量份、大青叶20重量份、玉柏14重量份、莲子25重量份、龙眼肉30重量份、刺五加16重量份、胃友12重量份、马尾连24重量份、升麻12重量份、茯神30重量份、侧柏叶11重量份、浮小麦33重量份、细辛25重量份、琴叶榕32重量份、皂荚2重量份、大枣35重量份、灵芝22重量份、栝楼皮18重量份、破布木30重量份、远志25重量份、锡叶藤13重量份、隔山消20重量份、透骨香3重量份、桂叶素馨22重量份和石榕14重量份。
当所述药物的剂型为颗粒剂时,其制备方法包括以下步骤:
第一步,将所述原料药材按所述比例混合,加相对于混合物4-8倍的醇浓度为85%-95%的乙醇,加热至沸腾回流3-5小时,过滤,采用渗漉法以每分钟1-2ml的速度缓缓渗漉,收集渗漉液,随后在真空度0.06-0.09Mpa下减压浓缩至50-60℃时相对密度为1.04-1.10的膏体,喷雾干燥,喷雾干燥机的进风温度160-175℃、出风温度80-85℃,随后粉碎成粉末,制成干膏粉;
第二步,在获得的干膏粉中加入相对于干膏粉质量0.2-0.4倍的蔗糖粉和0.1-0.2倍的糊精,制成颗粒,于40-50℃干燥,获得颗粒剂。
当所述药物的剂型为胶囊剂时,其制备方法包括以下步骤:
第一步,将所述原料药材按比例混合,加入相对于混合物质量2-4倍的醇浓度为85-95%的乙醇,加热回流1-3小时,提取,过滤获得第一提取液;过滤获得的药渣再加入相对于所述药渣质量1-2倍的醇浓度为85-95%的乙醇,加热回流1-3小时,提取,过滤获得第二提取液;将第一提取液和第二提取液合并,减压浓缩除去乙醇溶剂,干燥,获得干膏;
第二步,将第一步获得的干膏放置在超微粉碎机中粉碎1-2小时,粉碎,过筛,获得300目-400目的超微细粉;
第三步,在第二步获得的超微细粉中依次加入滑石粉、硬脂酸镁,进行混匀处理,即得胶囊内容物;所述超微细粉、硬脂酸镁和滑石粉的重量比为100∶0.15-0.5:0.15-0.5,将所述胶囊内容物装入胶囊壳体中,即得胶囊剂成品。
当所述药物的剂型为片剂时,其制备方法包括以下步骤:
第一步,将所述原料药材按比例混合,加入相对于混合物质量3~5倍的醇浓度为85%-95%的乙醇,加热回流4-6小时,提取,过滤获得第一提取液;过滤获得的药渣再加入相对于所述药渣质量2-4倍的醇浓度为90%-95%的乙醇,加热回流1-3小时,提取,过滤获得第二提取液;将第一提取液和第二提取液合并,减压浓缩除去乙醇溶剂,干燥,获得干膏;
第二步,将第一步获得的干膏放置在超微粉碎机中粉碎1-3小时,粉碎,过筛,获得400目-500目的超微细粉;
第三步,将第二步获得的超微细粉,加入相对于其质量0.1-0.2倍的微晶纤维素、0.15-0.3倍乳糖、0.2-0.3倍的淀粉,过筛,混合均匀,制粒,干燥,加入相对于超微细粉质量0.025-0.04倍硬脂酸镁,整粒,压片,制成。
以下采用实施例来详细说明本发明的实施方式,借此对本发明如何应用技术手段来解决技术问题,并达成技术效果的实现过程能充分理解并据以实施。
实施例1颗粒剂
本发明颗粒剂的制作过程为:取绞股蓝160g、酸枣仁280g、大青叶200g、玉柏140g、莲子250g、龙眼肉300g、刺五加160g、胃友120g、马尾连240g、升麻120g、茯神300g、侧柏叶110g、浮小麦330g、细辛250g、琴叶榕320g、皂荚20g、大枣350g、灵芝220g、栝楼皮180g、破布木300g和远志250g;
第一步,将所述原料药材按所述比例混合,加相对于混合物7倍的醇浓度为90%的乙醇,加热至沸腾回流4小时,过滤,采用渗漉法以每分钟2ml的速度缓缓渗漉,收集渗漉液,随后在真空度0.07Mpa下减压浓缩至55℃时相对密度为1.07的膏体,喷雾干燥,喷雾干燥机的进风温度170℃、出风温度80℃,随后粉碎成粉末,制成干膏粉;
第二步,在获得的干膏粉中加入相对于干膏粉质量0.3倍的蔗糖粉和0.2倍的糊精,制成颗粒,于45℃干燥,获得颗粒剂。
实施例2胶囊剂
本发明胶囊剂的制作过程为:取绞股蓝180g、酸枣仁250g、大青叶160g、玉柏300g、莲子180g、龙眼肉320g、刺五加120g、胃友100g、马尾连220g、升麻140g、茯神250g、侧柏叶100g、浮小麦330g、细辛260g、琴叶榕330g、皂荚20g、大枣350g、灵芝220g、栝楼皮150g、破布木300g和远志170g;
第一步,将所述原料药材按比例混合,加入相对于混合物质量3倍的醇浓度为90%的乙醇,加热回流2小时,提取,过滤获得第一提取液;过滤获得的药渣再加入相对于所述药渣质量1.5倍的醇浓度为95%的乙醇,加热回流2小时,提取,过滤获得第二提取液;将第一提取液和第二提取液合并,减压浓缩除去乙醇溶剂,干燥,获得干膏;
第二步,将第一步获得的干膏放置在超微粉碎机中粉碎2小时,粉碎,过筛,获得400目的超微细粉;
第三步,在第二步获得的超微细粉中依次加入滑石粉、硬脂酸镁,进行混匀处理,即得胶囊内容物;所述超微细粉、硬脂酸镁和滑石粉的重量比为100∶0.3:0.5,将所述胶囊内容物装入胶囊壳体中,即得胶囊剂成品。
实施例3片剂
本发明的片剂的制作过程为:取绞股蓝160g、酸枣仁280g、大青叶200g、玉柏140g、莲子250g、龙眼肉300g、刺五加160g、胃友120g、马尾连240g、升麻120g、茯神300g、侧柏叶110g、浮小麦330g、细辛250g、琴叶榕320g、皂荚20g、大枣350g、灵芝220g、栝楼皮180g、破布木300g、远志250g、锡叶藤130g、隔山消200g、透骨香30g、桂叶素馨220g和石榕140g;
第一步,将所述原料药材按比例混合,加入相对于混合物质量4倍的醇浓度为85%的乙醇,加热回流5小时,提取,过滤获得第一提取液;过滤获得的药渣再加入相对于所述药渣质量3倍的醇浓度为95%的乙醇,加热回流3小时,提取,过滤获得第二提取液;将第一提取液和第二提取液合并,减压浓缩除去乙醇溶剂,干燥,获得干膏;
第二步,将第一步获得的干膏放置在超微粉碎机中粉碎2小时,粉碎,过筛,获得450目的超微细粉;
第三步,将第二步获得的超微细粉,加入相对于其质量0.15倍的微晶纤维素、0.2倍乳糖、0.25倍的淀粉,过筛,混合均匀,制粒,干燥,加入相对于超微细粉质量0.03倍硬脂酸镁,整粒,压片,制成。
急性毒性试验:应用NIH小鼠40只,S痊愈F级,雌雄各半,体重18~25g,进行急性毒性试验。小鼠随机分为两组,每组20只,即对照组和给药组,实验前禁食12小时;将本发明的实施例3制备的片剂溶解在水中,(浓度为5.74g生药/ml,最高浓度)灌胃,灌胃容积为5ml/kg(即单次给药剂量为28.7生药/kg),对照组给予等量生理盐水,一天给药2次,给药间隔时间6小时,给药后连续观察14天,并记录小鼠的的毒性反应及死亡数。实验结果表明:与对照组比较,给药后小鼠未见明显差异,实验连续观察14天,小鼠全身状况、饮食、饮水、体重增长均正常。小鼠口服灌胃本发明的片剂LD50>28.7生药/kg,每日最大给药量为57.4生药/kg/日。本发明的药物临床用药量为4.6g生药/日/人,成人体重以60KG计,平均用药剂量为0.077g生药/kg/日。按体重计:小鼠(平均体重以21g计)口服灌胃本发明的药物的耐受量为临床用量的745倍。因此本发明的药物急性毒性低,临床用药安全。
长期毒性实验:将本发明实施例1的颗粒剂对小鼠按6.43、15.72和36.41g生药/kg连续用药16周(1.0ml/100g体重,每天2次)及停药4周后,结果表明:本发明药物对小鼠的毛发、行为、大小便、体重、脏器重量、血象、肝肾功能、血糖、血脂等指标均无明显影响,脏器肉眼没有发现异样变化和组织学检查结果表明,用药16周及停药4周后,小鼠各脏器均无明显改变。说明本发明药物对小鼠长期用药后毒性小,停药后也没有异样反应,应用安全。
蓄积毒性试验报告:试验方法:选用20只健康小白鼠,雌、雄各10只,以本发明实施例2的胶囊剂为对象,剂量设计每5天为一期,每期剂量分别为0.10LD50、0.15LD50、0.22LD50、0.34LD50、0.50LD50,此样品的雌性、雄性小鼠的LD50均为5000m份/k份BW(五个剂量为500、750、1100、1700、2500m份/k份BW)。每5天称体重一次,调整给药量,按0.1ml/10份BW经口灌胃。20天后,动物无死亡情况发生,试验结束,按递增剂量给受试物20天后,雌性、雄性动物均无死亡情况发生。
临床资料:
病例选择:选择2013年7月至2014年7月门诊或住院的200例桥本氏病患者,年龄20-60岁,200例患者满足如下条件:根据《中医症候鉴别诊断学》【2】诊断标准选择病例。初诊患者既符合HD诊断;对200例患者随机分为颗粒剂治疗组、胶囊剂治疗组、片剂治疗组和对照组,每个实验组50人。
诊断标准:1975年Fisher提出5项指标诊断方案:
1、甲状腺弥漫性肿大,质坚韧,表面不平或有结节;
2、TGAb、TMAb阳性;
3、血TSH升高;
4、甲状腺扫描有不规则浓聚或稀疏;
5、过氯酸钾排泌试验阳性。
5项中有2项者可拟诊为桥本氏病,具有4项者可确诊。一般在临床中只要具有典型桥本氏病临床表现(中年女性,甲状腺轻度肿大,质地韧),血清TGAb、TPOAb阳性即可临床诊断为桥本氏病。对临床表现不典型者,需要有高滴度的抗甲状腺抗体测定方能诊断。对这些患者如查血清TGAb、TPOAb为显著阳性,应给予必要的影像学检查协诊,如合并甲状腺功能减退症,对诊断十分有利。必要时应以FNAC或冰冻切片组织学检查确诊。
治疗方法:
药物治疗组中:
颗粒剂治疗组:使用本发明实施例1制备的颗粒剂,每日3次,一次一袋,每袋6g,每30天为1个疗程;
胶囊剂治疗组:服用本发明实施例2制备的胶囊剂,每日3次,一次1粒,每30天为一个疗程;
片剂治疗组:使用本发明实施例3制备的片剂,每日3次,一次1片,每30天为一个疗程。
对照组:服用左甲状腺素钠片,每日30μg,每30天为一个疗程。
疗效评价标准:根据《新药评价基础与实践》新药临床试验评定标准【3】制定。痊愈:症状消失,体征减轻,甲状腺功能恢复正常,抗体降低,可以停药。显效:症状消失,体征减轻,甲状腺功能恢复正常,抗体降低,可以停药。有效:症状减轻,甲状腺功能好转,体征及抗体变化不明显,需持续服药。无效:症状、体征及实验室检查均无明显好转或加重者。
治疗结果:
参见表1和表2,从表1可以看出,采用本发明的药物治疗桥本氏病,相对于传统药物在治疗效果上,具有显著的改进;从表2可以看出,采用本发明的药物治疗桥本氏病,相对于传统药物,在治疗疗程上显著缩短。
表1各组分别治疗4个疗程后临床疗效比较例
| 组别 | 例数 | 治愈数 | 显效数 | 有效数 | 无效数 | 总有效率(%) |
| 颗粒剂治疗组 | 50 | 29 | 17 | 2 | 2 | 96% |
| 胶囊剂治疗组 | 50 | 31 | 16 | 2 | 1 | 98% |
| 片剂治疗组 | 50 | 35 | 15 | 0 | 0 | 100% |
| 对照组 | 50 | 9 | 13 | 21 | 7 | 86% |
表2各组分别治疗4个疗程后治愈、显效和有效人数时间比较例(%)
| 组别 | 例数 | 第1个疗程 | 第2个疗程 | 第3个疗程 | 第4个疗程 |
| 颗粒剂治疗组 | 48 | 10(20.8%) | 11(22.9%) | 13(27.1%) | 14(29.2%) |
| 胶囊剂治疗组 | 49 | 10(20.4%) | 12(24.5%) | 13(26.5%) | 14(28.6%) |
| 片剂治疗组 | 50 | 11(22%) | 12(24%) | 13(26%) | 14(28%) |
| 对照组 | 43 | 5(11.6%) | 7(16.3%) | 11(25.6%) | 20(46.5%) |
根据上述表格内的临床统计可知,本发明提供的药物具有起效快、有效率高、疗效确切、安全性高、无毒副作用;同时对治疗组治愈、显效和有效人数的147例以及对照组治愈、显效和有效的43例患者随访1年半,结果统计,颗粒剂治疗组48例中治愈29例和显效17例无复发,有效2例中无复发1例,复发率为2.1%;胶囊剂治疗组49例中治愈31例和显效16例无复发,有效2例中复发1例,复发率为2.0%;片剂治疗组50例中治愈35例和显效15中都无复发,复发率为0%;对照组治愈、显效和有效人数43例,治愈9例中复发3例,显效的13例患者中复发7例,有效的21例患者中复发9例,复发率44.2%;上述复发是指患者治疗效果达到治愈、显效或有效后,在随访的1年半中明显出现治疗前的症状。
典型病例:王某,女性,45岁,甲状腺轻度肿大,质地韧,血清TGAb、TPOAb阳性症状,确诊为桥本氏病。服用本发明药物实施例1的颗粒剂,每日3次,一次一袋,每袋6g,用药一个疗程基本有效,继续用药半个月治愈,随访1年半未复发。
以上所述仅为本发明的较佳实施例,并不用以限制本发明,凡在本发明的精神和原则之内,所作的任何修改、等同替换、改进等,均应包含在本发明的保护范围之内。
Claims (10)
1.一种治疗桥本氏病的药物,其特征在于,包括以下原料药材:绞股蓝、酸枣仁、大青叶、玉柏、莲子、龙眼肉、刺五加、胃友、马尾连、升麻、茯神、侧柏叶、浮小麦、细辛、琴叶榕、皂荚、大枣、灵芝、栝楼皮、破布木和远志。
2.根据权利要求1所述的治疗桥本氏病的药物,其特征在于,所述药物中各原料药材的重量份数比为:绞股蓝10-20重量份、酸枣仁12-32重量份、大青叶15-25重量份、玉柏11-31重量份、莲子14-28重量份、龙眼肉13-33重量份、刺五加10-22重量份、胃友9-18重量份、马尾连13-27重量份、升麻9-15重量份、茯神15-30重量份、侧柏叶9-12重量份、浮小麦15-35重量份、细辛14-28重量份、琴叶榕12-36重量份、皂荚2-4重量份、大枣16-42重量份、灵芝14-36重量份、栝楼皮12-22重量份、破布木10-30重量份和远志15-35重量份。
3.根据权利要求1或2所述的治疗桥本氏病的药物,其特征在于,所述药物中各原料药材的重量份数比为:绞股蓝12-20重量份、酸枣仁14-30重量份、大青叶15-22重量份、玉柏12-30重量份、莲子15-25重量份、龙眼肉14-32重量份、刺五加12-20重量份、胃友10-16重量份、马尾连15-25重量份、升麻10-14重量份、茯神15-30重量份、侧柏叶9-12重量份、浮小麦15-35重量份、细辛15-28重量份、琴叶榕12-35重量份、皂荚2-3重量份、大枣20-40重量份、灵芝15-35重量份、栝楼皮13-21重量份、破布木13-30重量份和远志15-35重量份。
4.根据权利要求1-3任一项所述的治疗桥本氏病的药物,其特征在于,所述药物中各原料药材的重量份数比为:绞股蓝16重量份、酸枣仁28重量份、大青叶20重量份、玉柏14重量份、莲子25重量份、龙眼肉30重量份、刺五加16重量份、胃友12重量份、马尾连24重量份、升麻12重量份、茯神30重量份、侧柏叶11重量份、浮小麦33重量份、细辛25重量份、琴叶榕32重量份、皂荚2重量份、大枣35重量份、灵芝22重量份、栝楼皮18重量份、破布木30重量份和远志25重量份。
5.根据权利要求1-4任一项所述的治疗桥本氏病的药物,其特征在于,所述药物中各原料药材还包括:锡叶藤、隔山消、透骨香、桂叶素馨和石榕。
6.根据权利要求1-5任一项所述的治疗桥本氏病的药物,其特征在于,所述药物中各原料药材的重量份数比为:绞股蓝10-20重量份、酸枣仁12-32重量份、大青叶15-25重量份、玉柏11-31重量份、莲子14-28重量份、龙眼肉13-33重量份、刺五加10-22重量份、胃友9-18重量份、马尾连13-27重量份、升麻9-15重量份、茯神15-30重量份、侧柏叶9-12重量份、浮小麦15-35重量份、细辛14-28重量份、琴叶榕12-36重量份、皂荚2-4重量份、大枣16-42重量份、灵芝14-36重量份、栝楼皮12-22重量份、破布木10-30重量份、远志15-35重量份、锡叶藤12-24重量份、隔山消10-30重量份、透骨香3-5重量份、桂叶素馨15-25重量份和石榕10-20重量份。
7.根据权利要求1-6任一项所述的治疗桥本氏病的药物,其特征在于,所述药物中各原料药材的重量份数比为:绞股蓝16重量份、酸枣仁28重量份、大青叶20重量份、玉柏14重量份、莲子25重量份、龙眼肉30重量份、刺五加16重量份、胃友12重量份、马尾连24重量份、升麻12重量份、茯神30重量份、侧柏叶11重量份、浮小麦33重量份、细辛25重量份、琴叶榕32重量份、皂荚2重量份、大枣35重量份、灵芝22重量份、栝楼皮18重量份、破布木30重量份、远志25重量份、锡叶藤13重量份、隔山消20重量份、透骨香3重量份、桂叶素馨22重量份和石榕14重量份。
8.根据权利要求1-7任一项所述的治疗桥本氏病的药物的制备方法,其特征在于,当所述药物的剂型为颗粒剂时,其制备方法包括以下步骤:
第一步,将所述原料药材按所述比例混合,加相对于混合物4-8倍的醇浓度为85%-95%的乙醇,加热至沸腾回流3-5小时,过滤,采用渗漉法以每分钟1-2ml的速度缓缓渗漉,收集渗漉液,随后在真空度0.06-0.09Mpa下减压浓缩至50-60℃时相对密度为1.04-1.10的膏体,喷雾干燥,喷雾干燥机的进风温度160-175℃、出风温度80-85℃,随后粉碎成粉末,制成干膏粉;
第二步,在获得的干膏粉中加入相对于干膏粉质量0.2-0.4倍的蔗糖粉和0.1-0.2倍的糊精,制成颗粒,于40-50℃干燥,获得颗粒剂。
9.根据权利要求1-7任一项所述的治疗桥本氏病的药物的制备方法,其特征在于,当所述药物的剂型为胶囊剂时,其制备方法包括以下步骤:
第一步,将所述原料药材按比例混合,加入相对于混合物质量2-4倍的醇浓度为85-95%的乙醇,加热回流1-3小时,提取,过滤获得第一提取液;过滤获得的药渣再加入相对于所述药渣质量1-2倍的醇浓度为85-95%的乙醇,加热回流1-3小时,提取,过滤获得第二提取液;将第一提取液和第二提取液合并,减压浓缩除去乙醇溶剂,干燥,获得干膏;
第二步,将第一步获得的干膏放置在超微粉碎机中粉碎1-2小时,粉碎,过筛,获得300目-400目的超微细粉;
第三步,在第二步获得的超微细粉中依次加入滑石粉、硬脂酸镁,进行混匀处理,即得胶囊内容物;所述超微细粉、硬脂酸镁和滑石粉的重量比为100∶0.15-0.5:0.15-0.5,将所述胶囊内容物装入胶囊壳体中,即得胶囊剂成品。
10.根据权利要求1-7任一项所述的治疗桥本氏病的药物的制备方法,其特征在于,当所述药物的剂型为片剂时,其制备方法包括以下步骤:
第一步,将所述原料药材按比例混合,加入相对于混合物质量3~5倍的醇浓度为85%-95%的乙醇,加热回流4-6小时,提取,过滤获得第一提取液;过滤获得的药渣再加入相对于所述药渣质量2-4倍的醇浓度为90%-95%的乙醇,加热回流1-3小时,提取,过滤获得第二提取液;将第一提取液和第二提取液合并,减压浓缩除去乙醇溶剂,干燥,获得干膏;
第二步,将第一步获得的干膏放置在超微粉碎机中粉碎1-3小时,粉碎,过筛,获得400目-500目的超微细粉;
第三步,将第二步获得的超微细粉,加入相对于其质量0.1-0.2倍的微晶纤维素、0.15-0.3倍乳糖、0.2-0.3倍的淀粉,过筛,混合均匀,制粒,干燥,加入相对于超微细粉质量0.025-0.04倍硬脂酸镁,整粒,压片,制成。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510983640.3A CN105412673A (zh) | 2015-12-24 | 2015-12-24 | 一种治疗桥本氏病的药物及其制备方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510983640.3A CN105412673A (zh) | 2015-12-24 | 2015-12-24 | 一种治疗桥本氏病的药物及其制备方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN105412673A true CN105412673A (zh) | 2016-03-23 |
Family
ID=55491516
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510983640.3A Withdrawn CN105412673A (zh) | 2015-12-24 | 2015-12-24 | 一种治疗桥本氏病的药物及其制备方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105412673A (zh) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106309579A (zh) * | 2016-09-14 | 2017-01-11 | 中国中医科学院医学实验中心 | 一种用于治疗雌激素分泌水平低下相关疾病的中药组方 |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102357191A (zh) * | 2011-10-31 | 2012-02-22 | 刘爱武 | 一种治疗桥本氏病的药物组合物 |
| CN102579808A (zh) * | 2012-04-06 | 2012-07-18 | 济南康众医药科技开发有限公司 | 一种治疗桥本氏病的药物组合物 |
| CN103040995A (zh) * | 2012-10-12 | 2013-04-17 | 王春红 | 一种治疗桥本病的药物 |
| CN103948867A (zh) * | 2014-04-30 | 2014-07-30 | 郭如英 | 甲状腺桥本氏病解郁破结的中药制剂及制备方法 |
| CN104056174A (zh) * | 2014-07-03 | 2014-09-24 | 吴晓青 | 一种辅助治疗桥本氏病的中药组合物 |
-
2015
- 2015-12-24 CN CN201510983640.3A patent/CN105412673A/zh not_active Withdrawn
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102357191A (zh) * | 2011-10-31 | 2012-02-22 | 刘爱武 | 一种治疗桥本氏病的药物组合物 |
| CN102579808A (zh) * | 2012-04-06 | 2012-07-18 | 济南康众医药科技开发有限公司 | 一种治疗桥本氏病的药物组合物 |
| CN103040995A (zh) * | 2012-10-12 | 2013-04-17 | 王春红 | 一种治疗桥本病的药物 |
| CN103948867A (zh) * | 2014-04-30 | 2014-07-30 | 郭如英 | 甲状腺桥本氏病解郁破结的中药制剂及制备方法 |
| CN104056174A (zh) * | 2014-07-03 | 2014-09-24 | 吴晓青 | 一种辅助治疗桥本氏病的中药组合物 |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106309579A (zh) * | 2016-09-14 | 2017-01-11 | 中国中医科学院医学实验中心 | 一种用于治疗雌激素分泌水平低下相关疾病的中药组方 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101249241B (zh) | 一种根治肺结核的药物及其制备方法 | |
| CN103736036A (zh) | 一种治疗非酒精性脂肪性肝病的药物及其制备方法 | |
| CN105435197A (zh) | 一种治疗桥本氏病的药物组合物及其制备方法 | |
| CN106511840A (zh) | 一种固本降糖组合物及其制备方法 | |
| CN106215118A (zh) | 抗肿瘤的保健制剂及其制备方法 | |
| CN103041112B (zh) | 一种治疗单纯肥胖性脂肪肝的中药 | |
| CN114748603A (zh) | 一种防治新冠病毒肺炎变异或复阳的药食同源组合物和应用 | |
| CN105412673A (zh) | 一种治疗桥本氏病的药物及其制备方法 | |
| CN106806842A (zh) | 一种治疗乳腺增生结节的中药组合物及其制备方法 | |
| CN105853901A (zh) | 癌症病人放化疗期间服用的制剂及制法 | |
| CN118750561B (zh) | 一种用于新冠病毒感染恢复期的中药组合物及其制备方法和应用 | |
| CN104667252A (zh) | 一种用于治疗急性肠胃炎的中药 | |
| CN104083548A (zh) | 一种治疗卵巢囊肿的中药组合物及其制备方法 | |
| CN109646665A (zh) | 杜仲清肺抗癌固体茶及其制备方法 | |
| CN114712470B (zh) | 一种治疗男士肾亏的药物及其制备方法 | |
| CN110025760A (zh) | 一种治未病的中药组合物及其制备方法 | |
| CN107952036A (zh) | 一种降血糖的中药制剂及其制备方法 | |
| CN103656199A (zh) | 一种治疗肾阴不足证型咳嗽的中药 | |
| CN105998860A (zh) | 一种治疗骨关节病的中药组合物 | |
| CN104606537A (zh) | 改善化疗所致心肌缺血损伤的益气养血药膳及制备方法 | |
| CN104306496A (zh) | 风湿性心脏病补益心脾制剂及制备方法 | |
| CN105250618A (zh) | 一种治疗肝硬化的抗病毒中药组合物及其制备方法 | |
| CN105288166A (zh) | 一种用于甲状腺肿大的中药组合物及其制备方法 | |
| CN104706767A (zh) | 一种用于治疗急性肾炎的中药 | |
| CN104606562A (zh) | 一种治疗胸腔积液的行水通络制剂及制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WW01 | Invention patent application withdrawn after publication |
Application publication date: 20160323 |
|
| WW01 | Invention patent application withdrawn after publication |